Hvsen Biotechnology Co., Ltd. (300871.SZ)
CNY 11.77
(-0.17%)
CNY 11.77
(-0.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.01 Billion | 1.02 Billion | 996.21 Million | 777.45 Million | 427.21 Million | 421.87 Million |
| Cost of Revenue | 809.95 Million | 797.53 Million | 725.49 Million | 489.58 Million | 263.54 Million | 238.14 Million |
| Gross Profit | 209.8 Million | 225.36 Million | 270.72 Million | 287.87 Million | 163.66 Million | 183.72 Million |
| Operating Expenses | 194.71 Million | 146.03 Million | 134.53 Million | 109.84 Million | 80.36 Million | 88.24 Million |
| Selling, General and Administrative Expenses | 155.4 Million | 59.51 Million | 64.48 Million | 66.26 Million | 13.65 Million | 22.27 Million |
| Research and Development Expenses | 27.65 Million | 40.13 Million | 46.88 Million | 28.38 Million | 21.1 Million | 20.35 Million |
| Other Expenses | 11.65 Million | -2.44 Million | -195.49 Thousand | -484.89 Thousand | 3.06 Million | 2.43 Million |
| Cost and Expenses | 1 Billion | 943.57 Million | 860.02 Million | 599.43 Million | 343.91 Million | 326.39 Million |
| Operating Income | 15.08 Million | 59.15 Million | 151.02 Million | 176.51 Million | 78.55 Million | 81.49 Million |
| Interest Expense | 28.21 Million | 18.37 Million | 2.87 Million | 2.3 Million | 5.23 Million | 3.82 Million |
| Income Tax Expense | -4.33 Million | 4 Million | 17.96 Million | 25.87 Million | 9.83 Million | 10.26 Million |
| Earnings before Tax | 12.44 Million | 56.7 Million | 150.83 Million | 176.03 Million | 78.6 Million | 81.66 Million |
| Net Income | 16.78 Million | 52.7 Million | 132.86 Million | 150.15 Million | 68.76 Million | 71.4 Million |
| Earnings Per Share Basic | 0.10 | 0.32 | 0.80 | 0.91 | 0.41 | 0.59 |
| Earnings Per Share Diluted | 0.10 | 0.32 | 0.80 | 0.91 | 0.41 | 0.59 |
| Weighted Average Shares Outstanding | 165.98 Million | 165.43 Million | 166.08 Million | 165.76 Million | 165.76 Million | 120.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 165.98 Million | 165.43 Million | 166.08 Million | 165.76 Million | 165.76 Million | 120.33 Million |
| Gross Margin | 0.21 | 0.22 | 0.27 | 0.37 | 0.38 | 0.44 |
| EBIT Margin | 0.16 | 0.15 | 0.18 | 0.26 | 0.24 | 0.27 |
| Profit Margin | 0.02 | 0.05 | 0.13 | 0.19 | 0.16 | 0.17 |
| EBITDA | 161.37 Million | 138.22 Million | 182.64 Million | 197.73 Million | 93.44 Million | 96.09 Million |
| Earnings Before Tax Margin | 0.01 | 0.06 | 0.15 | 0.23 | 0.18 | 0.19 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 353.55 Million | 227.16 Million | 204.5 Million | 1.01 Billion | 328.37 Million | 242.3 Million |
| Cost of Revenue | 308.89 Million | 204.35 Million | 159.93 Million | 806.46 Million | 261.73 Million | 195.98 Million |
| Gross Profit | 44.66 Million | 22.8 Million | 44.56 Million | 213.29 Million | 66.63 Million | 46.31 Million |
| Operating Expenses | 45.88 Million | 31.41 Million | 45.15 Million | 171.35 Million | 47.31 Million | 45.33 Million |
| Selling, General and Administrative Expenses | 34.9 Million | 20.58 Million | 28.58 Million | - | -26.74 Million | 60.62 Million |
| Research and Development Expenses | 12.49 Million | 9.77 Million | 14.53 Million | - | 13.39 Million | 11.96 Million |
| Other Expenses | 1.51 Million | -1.05 Million | -2.03 Million | -2.64 Million | -292.97 Thousand | -94.88 Thousand |
| Cost and Expenses | 354.77 Million | 235.76 Million | 205.08 Million | 977.82 Million | 309.05 Million | 241.31 Million |
| Operating Income | -1.22 Million | -8.6 Million | -585.01 Thousand | 15.08 Million | -1.9 Million | -2.62 Million |
| Interest Expense | 12.67 Million | 11.1 Million | 10.41 Million | 28.21 Million | 11.59 Million | 6.2 Million |
| Income Tax Expense | -780.58 Thousand | -7.66 Million | -5.14 Million | -4.33 Million | -4.1 Million | -1.7 Million |
| Earnings before Tax | 3.48 Million | -43.14 Million | -21.54 Million | 12.44 Million | -2.19 Million | -2.72 Million |
| Net Income | 4.22 Million | -35.47 Million | -16.4 Million | 16.78 Million | 1.9 Million | -1.02 Million |
| Earnings Per Share Basic | 0.03 | -0.22 | -0.10 | - | 0.01 | -0.01 |
| Earnings Per Share Diluted | 0.03 | -0.22 | -0.10 | - | 0.01 | -0.01 |
| Weighted Average Shares Outstanding | 165.01 Million | 163.37 Million | 165.88 Million | 165.98 Million | 163.37 Million | 163.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 165.01 Million | 163.37 Million | 165.88 Million | 165.98 Million | 163.37 Million | 163.37 Million |
| Gross Margin | 0.13 | 0.10 | 0.22 | 0.21 | 0.20 | 0.19 |
| EBIT Margin | 0.05 | 0.08 | 0.02 | - | 0.08 | 0.02 |
| Profit Margin | 0.01 | -0.16 | -0.08 | 0.02 | 0.01 | -0.00 |
| EBITDA | 16.16 Million | 19.07 Million | 4.81 Million | - | 26.87 Million | 5.41 Million |
| Earnings Before Tax Margin | -0.00 | -0.04 | -0.00 | 0.01 | -0.01 | -0.01 |
002625
CSMG3
IFSH
NNCSF
5958
VIKRAMTH